Pear Therapeutics CEO Corey McCann, MD, PhD delves into the potential digital therapeutics have in helping people who abuse drugs and alcohol. The company’s product pipeline includes potential treatment for schizophrenia, combat-PTSD, generalized anxiety disorder, insomnia and traumatic brain injury.